SOT 2021 Recap: Spotlight on Dose-Response and the MDCPSS Best Overall Abstract Award Winner š
SenzaGen had a busy program at SOT 2021. To highlight our expanding capabilities inĀ in vitroĀ skin toxicology, we took part in several activities and presented our novel assays for quantitative skin sensitizing potency assessmentĀ and medical device testing.
Exhibitor Hosted Session: Dose-response for predicting skin sensitization potency
Listen to SenzaGen’s Chief Scientist Dr Henrik Johansson presenting the latest development on GARDā¢skin Dose-Response, our novel in vitro assay for quantitative skin sensitizing potency assessment:
Workshop: Applicability domains and future of non-animal tests for skin sensitization
Learn from Dr Andy Forreryd how GARDā¢ and other in vitro assays can be used to fill data gaps in sensitizing hazard and potency assessment of chemicals:
Posters by SenzaGen and jointly with Corteva
Quantitative Sensitizing Potency Assessment Using GARDā¢skin Dose-Response| Request a copy
GARDā¢skin and GARDā¢potency: A Proof-of-Concept Study to Investigate the Applicability Domain for Agrochemical Formulations| View abstract
š MDCPSS Best Overall Abstract Award Winnerš
Applicability Domain of the GARDā¢skin Medical Device Test for In Vitro Skin Sensitization Testing of Medical Devices| Request a copy